Stryker Valuation Multiples

Stryker Overview

About Stryker

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.

Founded

1946

HQ

Employees

56.0K

Website

stryker.com

Sectors

Autonomous AI & RoboticsMedical DevicesDeepTechHealthTech

Financials (LTM)

Revenue: $26B

EBITDA: $7B

EV

$160B

Valuation Multiples

Multiples.vc

Start free trial

Stryker Financials

Stryker reported last 12-month revenue of $26B and EBITDA of $7B.

In the same LTM period, Stryker generated $17B in gross profit, $7B in EBITDA, and $5B in net income.

Stryker P&L

In the most recent fiscal year, Stryker reported revenue of $25B and EBITDA of $7B.

Stryker expects next 12-month revenue of XXX and NTM EBITDA of XXX

Stryker Stock Performance

Stryker has current market cap of $148B, and enterprise value of $160B.

Stryker's stock price is $387.02.

Stryker Valuation Multiples

Stryker trades at 6.2x EV/Revenue multiple, and 21.7x EV/EBITDA.

Stryker Financial Valuation Multiples

As of March 22, 2026, Stryker has market cap of $148B and EV of $160B.

Equity research analysts estimate Stryker's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Stryker has a P/E ratio of 27.5x.

Stryker Margins & Growth Rates

Stryker's revenue in the last 12 month grew by 9%.

Stryker's revenue per employee in the last FY averaged $0.5M.

Stryker's rule of 40 is 38% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Stryker's rule of X is 51% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Stryker Public Comps

See public comps and valuation multiples for other Autonomous AI & Robotics and Medical Devices comps.

Stryker M&A Activity

Stryker acquired XXX companies to date.

Last acquisition by Stryker was on XXXXXXXX, XXXXX. Stryker acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Stryker Investment Activity

Stryker invested in XXX companies to date.

Stryker made its latest investment on XXXXXXXX, XXXXX. Stryker invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).